Met a milestone, an a $2 million payment from gsk and we drop. We no they are not making money, but everything seems to be on track for drug approval in the near future. Don't get it!
Earnings are a non-issue at this point, they do have a decent amount of cash, hang on good things coming.
Sentiment: Strong Buy
I agree.....stock should be over 35, everything you read is positive
Climbing now into earnings!